C12N 2501/599
With cd designations not provided for elsewhere
Official title: with CD designations not provided for elsewhere
C12N2501/599 (With cd designations not provided for elsewhere) appears on 353 US grants and 794 published applications in this corpus.
Search patents in C12N- Granted patents
- 353
- Published applications
- 794
- Assignees
- 353
- Inventors
- 1,310
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 3 | 3 |
| 2002 | 4 | 8 |
| 2003 | 2 | 8 |
| 2004 | 3 | 13 |
| 2005 | 4 | 7 |
| 2006 | 2 | 12 |
| 2007 | 3 | 9 |
| 2008 | 3 | 8 |
| 2009 | 3 | 9 |
| 2010 | 7 | 12 |
| 2011 | 6 | 8 |
| 2012 | 6 | 10 |
| 2013 | 7 | 19 |
| 2014 | 7 | 15 |
| 2015 | 11 | 22 |
| 2016 | 11 | 30 |
| 2017 | 9 | 37 |
| 2018 | 17 | 60 |
| 2019 | 32 | 48 |
| 2020 | 20 | 63 |
| 2021 | 31 | 73 |
| 2022 | 34 | 78 |
| 2023 | 26 | 84 |
| 2024 | 31 | 67 |
| 2025 | 41 | 57 |
| 2026 | 28 | 34 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for haematopoietic stem cell transplantation8 Sep 2026US 12,729,371 B2Fondazione Telethon
- Treatment of disc degenerative disease and stimulation of proteoglycan synthesis by fibroblast conditioned media and formulations thereof25 Aug 2026US 12,716,055 B2Fibrobiologics, Inc.
- Manufacturing process for making t cells expressing chimeric antigen receptors4 Aug 2026US 12,698,317 B2Crispr Therapeutics AG
- Populations of enriched regulatory T cells and methods for producing same28 Jul 2026US 12,692,478 B2Cellenkos, Inc.
- Methods for engineering allogeneic and highly active T cell for immunotheraphy14 Jul 2026US 12,680,076 B2Cellectis
- Cd4+ cytotoxic t cells and methods of use thereof8 Oct 2026US 2026/0308522 A1Dana-Farber Cancer Institute, Inc.
- Compositions and methods for propogating insulin and glucagon secreting cells from type 1 diabetic pancreatic tissue and therapeutic uses thereof8 Oct 2026US 2026/0308529 A1Imagine Pharma LLC
- Populations of enriched regulatory t cells and methods for producing same1 Oct 2026US 2026/0297523 A1Cellenkos, Inc.
- Programming B Cells to Produce IL-27 to Treat Inflammatory Diseases10 Sep 2026US 2026/0263596 A1Board of Regents, The University of Texas System
- Enhanced Expansion of Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy3 Sep 2026US 2026/0258358 A1Board of Regents, The University of Texas System
Most cited
By later US patents
- Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells512US 6,352,694 B1Genetics Institute, Inc. · 2002
- Methods for selectively stimulating proliferation of T cells452US 6,534,055 B1Genetics Institute, Inc. · 2003
- Methods of treating HIV infected subjects386US 6,905,680 B2Genetics Institute, Inc. · 2005
- Methods for selectively stimulating proliferation of T cells385US 6,887,466 B2Genetics Institute, Inc. · 2005
- Methods for selectively stimulating proliferation of T cells384US 6,905,681 B1Genetics Institute, Inc. · 2005